Lung doses resulting from inhalation of plutonium aerosols are highly dependent on the assumed rate of particle clearance, which occurs by two competing processes: (1) particle transport clearance to the alimentary tract and to the thoracic lymph nodes and (2) clearance to systemic tissues, which occurs by dissolution of particles in lung fluid followed by uptake to blood, which is a process collectively known as absorption. Unbiased and accurate estimates of the values of lung absorption parameters are required to obtain reliable estimates of lung dose, particularly those inferred from urine bioassay. Parameter values governing the rate of absorption are best estimated from data, such as autopsy measurements of plutonium in the lungs and systemic tissues, which directly relate to the exposed workers of interest. However, because the mathematical models that determine clearance from the lungs and systemic tissues are complex and consist of many parameters, estimates of model parameter values are subject to significant uncertainties. With this in mind, this paper uses a Bayesian approach to estimate one of the most important dissolution parameters: the slow rate of dissolution. This is estimated for both plutonium nitrate and plutonium oxide bearing aerosols in the lungs of former workers of the Mayak Production Association. A value of 2.6 × 10 −4 d −1 is estimated for plutonium nitrates, and 4.7 × 10 −5 d −1 for plutonium oxides.
INTRODUCTION
The magnitude of lung doses resulting from inhaled plutonium aerosols is highly dependent on the rate at which deposited particulates are cleared from the lungs. Clearance is modelled by two competing processes: mechanical particle transport clearance to the alimentary tract and thoracic lymph nodes (LNTH), and by absorption to blood. In the ICRP Publication 66, human respiratory tract model (HRTM) (1) absorption occurs by dissolution of the inhaled particulates followed by uptake to blood. The latter is assumed to be instantaneous unless the dissolved ions of the radionuclide become bound to airway walls. Plutonium absorbed to blood is either cleared to systemic tissues, principally the liver and skeleton (2) , or is excreted in urine. A consequence of the latter is that the assumed rate of absorption has a compounding effect on the magnitude of lung doses estimated from urine bioassay, for several reasons: firstly, because it directly affects the rate of lung clearance (and hence lung dose per unit intake), and secondly, because it also affects the magnitude of intakes estimated from urine bioassay measurements (intake per unit measurement). Therefore, given the same urine bioassay data and exposure scenario, small differences in the rate of absorption assumed by different dose assessors can lead to significant differences in estimates of lung dose.
To compound this problem, a recent review by Puncher et al. (3) showed that significant uncertainties exist on current estimates of absorption parameter values for plutonium nitrates and oxides, which are largely derived from animal data. The review highlighted several limitations of the data used in Puncher et al. (3) :
• The physico-chemical form, and hence absorption characteristics, of the material inhaled by workers may differ from (ostensibly) the same material administered to animals.
• The often necessarily short duration of animal studies makes it difficult to precisely determine the rate of slow dissolution, which is the parameter generally having the greatest impact on lung doses estimated from urine bioassay (3, 4) .
The rate of absorption of a given material may differ between animals and humans. In fact, inter-species comparisons of lung clearance of mono-disperse aerosols of cobalt oxide particles (5, 6) have shown that differences in absorption do exist. In these studies, the initial rate of absorption of the material varied by a factor of 3-6 between species.
As a consequence, Puncher et al. (3) recommended that values of absorption parameters should be, wherever possible, determined from data that directly relate to the exposed workers of interest. Such an approach was used by Khokhryakov et al. (7) who estimated values for some of the absorption parameters from 502 sets of autopsy measurements of former plutonium workers of the Mayak Production Association (MPA). Those authors used a non-linear optimisation fitting process to simultaneously estimate values of the slow dissolution rate, s s , and permanent bound fraction, f b , for plutonium nitrates, plutonium 'mixtures' and plutonium oxides. However, there are also several limitations to the approach adopted in that study, namely:
(1) Estimates of model parameter values are potentially subject to significant uncertainty because the biokinetic models of clearance from the lungs and systemic tissues are complex, model parameter values are uncertain and data are subject to significant measurement uncertainty. For example, although the fitting procedure considered differences in particle transport clearance between smokers and non-smokers, it did not account for the significant variability in the rate of clearance between workers and its likely effect on estimates of absorption parameter values. ( 2) The analysis used the ICRP Publication 66 (1) representation of particle transport clearance that is now known to under-predict the longterm retention of insoluble particulates from the alveolar-interstitial (AI) region (8, 9) . The ICRP HRTM has since been revised to account for it (10) . ( 3) The analysis invoked the use of a permanent bound fraction to explain long-term retention of plutonium in interstitial tissue, which may well be explained by delayed particle transport clearance in the revised HRTM. This assumption has its own problems since the permanent bound fraction was also assumed to occur in the upper airways, significantly increasing the dose there.
This work attempts to address these limitations by using the revised HRTM (10) and applying a Bayesian approach to estimate the rate of absorption of plutonium nitrate and oxide bearing materials, and the uncertainty on these estimates, from a sample of MPA worker autopsy data, considering prior uncertainties on the rates governing particle transport clearance from the lungs.
In the Bayesian framework, the state of knowledge of a model parameter value is defined as a probability distribution. This knowledge is updated by the application of Bayes' theorem and relevant measurement data:
where P(M|X) is the probability of observing the new data M, given parameter values X. The probability density function, P(X), describes the initial state of knowledge regarding X; for this reason it is referred to as the prior distribution. The updated information regarding the parameter is defined by the probability density function, P(X|M): it is the distribution of X conditioned on the data M, and is referred to as the posterior distribution. It represents the sum total of knowledge regarding the model parameters represented by the data and the priors. In the present context, M is a vector of the measurements of plutonium in the lungs and systemic tissues, and X is a vector of HRTM parameter values and intake. Such a Bayesian approach has been used in internal radiation protection to identify intakes in routine monitoring (11) , and estimate uncertainties on doses from bioassay data (3, 12, 13) . In this paper, consideration of absorption is confined to dissolution; dissolution in conjunction with a permanent bound fraction is addressed in a companion paper in this series (14) . Because of the significant time elapsed between exposure and death, this analysis is confined to estimation of the slow dissolution rate, s s , and assumes fixed values for the rapid fraction, f r and rapid dissolution rate, s r .
METHODS

The MPA workers
The analysis used the data from 60 MPA plutonium workers; 40 were exposed to plutonium nitrates and 20 to plutonium oxides.
Plutonium nitrate exposures
Twenty cases of the 40 cases were considered where the workers were reported to have spent all their time working with plutonium nitrate materials. These cases were used to obtain final estimates of the slow dissolution rate, s s for plutonium nitrate; for brevity, these are referred to as the 'test cases'. The remaining 20 worked mostly under conditions where they would have had plutonium nitrate exposure but also spent variable amounts of time in locations where either:
(1) No exposure to plutonium is thought to have occurred (e.g. the workers were located in the reactor plant or other auxiliary locations) or (2) The workers spent time at other locations where limited exposure to other forms of plutonium may have occurred (mixtures of nitrates and oxides). However, these exposures occurred at later times where levels of exposure were expected to be much lower, so that exposure to exclusively plutonium nitrate typically constituted 80% or more of the total intake.
The 20 cases categorised under (1) or (2) were included as 'controls' (and for brevity are hereafter referred to as such) in order to assess the reliability of estimates of s s determined from the analysis of workers exposed to oxides, described as follows.
Plutonium oxide exposures
Only 20 cases of plutonium oxide exposures were available for analysis, and of these, only two spent their time working exclusively under conditions where they would only have been exposed to plutonium oxides. The remaining workers had work histories similar to the nitrate controls categorised as (1) or (2), above, but nevertheless would mostly have been exposed to plutonium oxide. Thus any discrepancies between the values of s s determined for the nitrate test cases and control cases would indicate that the estimates derived from these oxide cases are potentially unreliable.
The data
The data for each worker consisted of autopsy measurements of systemic burden and lung burden.
Systemic burden
Measurements of plutonium in skeleton and liver were combined to give a single measurement.
Combining the liver and skeleton measurements was convenient for two reasons:
(1) Estimates of the values of HRTM clearance parameters are dependent only on the ratio of the lung: systemic burden, and so combining the measurements eliminates the need to include an additional parameter to fit the relative liver to skeleton burden for each worker that arises due to natural inter-subject variability in uptake by these tissues. (2) Differences in ratios of lung to systemic activity between healthy and diseased subjects were found not to be statistically significant (authors calculations, based on 481 sets of autopsy data). Consequently, combining the measurements removes the need to account for the effects of alcohol-related liver disease (which affects the liver to skeleton activity ratio), which was a consideration for some workers included in the analysis.
Lung burden
Measurements of plutonium in lungs and LNTH were combined to give a single measurement of activity in all lung compartments that are subject to clearance by absorption. This was done primarily to facilitate rapid convergence of the Monte Carlo calculations, particularly the Weighted Likelihood Monte Carlo Sampling (WeLMoS) analyses of the individual worker datasets. Preliminary Markov Chain Monte Carlo (MCMC) runs showed that estimates of the slow dissolution rate, s s , were the same whether the lung and lymph node measurements were considered separately or combined into a single measurement. For both datasets, the uncertainties on the autopsy data were assumed to be normally distributed. Estimates of measurement uncertainties (15, 16) derived for skeleton, liver, lung and LNTH were combined (liver plus skeleton; lung plus LNTH) by propagation of errors assuming that the measurement uncertainties are independent.
The analyses did not include urine bioassay for two reasons. Firstly, including urine bioassay did not significantly affect estimates of the slow dissolution rate, s s when combined with the autopsy data (large lognormal uncertainties meant that the urine bioassay data were uninformative relative to the autopsy data). Secondly, the analyses were conducted concurrently with an analysis to determine whether use of the urine data might result in biased estimates of intake and dose (17) .
Intake regimes
An intake regime was derived for each case by superimposing the worker's exposure history on the stepwise chronic intake regime (18) . The intake pattern within each period was assumed to be represented by a constant daily rate of intake (Bq d
−1
).
Biokinetic models
All analyses were performed assuming the revised ICRP Publication 67 (19) biokinetic model for plutonium published by Leggett et al. (2) . Because the liver and skeleton measurements were combined, no adjustments were made to the model to account for alcohol-related liver disease. The revised HRTM (10) , including reference particle transport clearance rates and breathing parameters, derived for the analysis of Mayak workers under MWDS-2013 (17) was also used in this analysis.
Prior distributions
The prior distributions used to analyse the new autopsy data are summarised in Table 1 .
Absorption parameters
In order to permit only the data to inform on values of this parameter, a uniform prior distributionwhich shows no preference for one parameter value over another-was assumed for s s . For nitrates, the rapid fraction and rapid dissolution rate were fixed at the reference values of 0.17 and 1 d −1 , respectively; for oxides, the rapid fraction and rapid dissolution rate were fixed at the reference values of 0.0026 and 1 d −1 , respectively (17) .
Particle transport parameters
The prior distributions assumed for the clearance rates from the alveolar region (ALV) to the bronchiolar region (bb) and interstitial region (INT) are those assumed for the analysis of Mayak workers under MDWS-2013 (17) . Because the lung and lymph node measurements were combined, the rate from the INT to the LNTH was fixed at the model reference value of 0.00003 d −1 .
Intake
A broad uniform prior distribution for intake was assumed in all analyses with a lower bound of 0 Bq and upper bound of 1 × 10 6 Bq. This was used because an informative prior distribution for intake had yet to be derived for the MPA workers when this work was undertaken. However, posterior estimates were compared with the level of intake expected for each worker specified by the intake prior subsequently derived (17) for the calculation of doses for the cohort of MPA workers under MWDS-2013.
Bayesian calculations
Two types of calculation were performed on the nitrate and oxide exposure histories:
Calculation 1: The WeLMoS method (20) was applied in order to obtain posterior estimates of intake, the parameter s s and the particle transport parameter values for each worker. The marginal distribution of s s for each worker was calculated using the following equation:
where L is a vector consisting of values of the particle transport rates (ALV to bb region; ALV to INT region) and intake; M is a vector consisting of two autopsy measurements (lung combined with LNTH; and skeleton combined with liver). The marginal distribution (the probability distribution of values of a given parameter without reference to the values of other model parameters in the joint probability distribution of all parameters) of other parameters (in L) is obtained by integration of the joint posterior distribution (the right hand side of Equation (2)).
For each analysis, the WeLMoS algorithm was performed using 2000 vectors of parameters sampled from a Latin-Hypercube constructed from the prior distributions given in Table 1 ; the joint posterior distribution of model parameters and intakes (the right hand side of Equation (2)) was calculated using 200 linearly spaced values of intake in the conventional manner (20) . Three separate runs were performed to monitor convergence. The calculations were considered to have converged if posterior means were within 10%.
Calculation 2: MCMC was applied to obtain 'shared' estimates of the slow dissolution rate, s s , for groups of the nitrate or oxide exposure histories; the groups consisted of:
• Four subgroups of the 20 cases, each consisting of five nitrate (or oxide) cases. It was expected that the analysis assuming shared estimates of s s would be superior to single estimates, and so to test the success of this methodology, the 20 cases were divided into four equal subgroups and the shared analysis was also carried out on each of the subgroups.
• A single group consisting of all 20 nitrate (or oxide) cases. The shared analysis of this group is assumed to lead to the best estimate of s s .
Under these circumstances, the quantity calculated is a posterior distribution of single values of s s for the group of workers in question, and a distribution of particle transport values for every worker in the group. The distribution of s s is jointly determined by all of the worker data in the group. However, the distribution of particle transport parameter values obtained for every worker is only directly informed by the data for that particular worker; however, it may also be informed indirectly by the data from all of the workers in the group through an indirect correlation with s s (because its value is shared by all workers included in the analysis). As with Calculation 1, posterior estimates of s s can be obtained using Equation (2) . Under these circumstances, the posterior distribution of s s is still a distribution of single values (because it is shared); however, L is a matrix of n × 3 parameters (i.e. intake and the two particle transport clearance rates), and M is an n × 2 matrix of autopsy data, where n = 5 or n = 20 workers, depending on the number of workers included in the group. The Calculation 2 analysis was performed using the MCMC method described by Puncher and Birchall (20) , and Puncher et al. (21) . The MCMC routines used IMBA Professional Plus (22) to calculate bioassay predictions. The MCMC method is an implementation of the single component Metropolis algorithm (23) . Briefly:
(1) For each analysis, two chains were initiated using different values of parameters with positive density in the posterior distribution. (2) Table 2 summarises the results of the analysis of the plutonium nitrate 'test' cases (workers who spent their careers working exclusively with plutonium nitrate materials) that were also used to obtain shared estimates of s s (described below). The main points of interest are:
RESULTS
Bayesian analysis of individual nitrate and oxide case histories
Plutonium nitrates
• With the exception of case 8795 (which appears to exhibit behaviour more consistent with the oxides, below), the mean and median s s values are around 2-4 × 10
, although the distributions are fairly broad in some cases, with geometric 95% ranges of around a factor of 10.
• There was not a statistically significant difference in the values of s s determined from the 20 nitrate test cases compared with the 20 nitrate controls (workers who spent some of their work history performing non-plutonium-related tasks, and/or were potentially exposed to plutonium materials other than nitrates) (p < 0.43) . The difference between the values of s s determined for the 20 plutonium oxide cases analysed individually versus the values of s s determined from the 20 plutonium nitrate test cases is statistically significant (p~0).
• For the particle transport clearance parameters, posterior estimates were broad with geometric standard deviations (GSDs) of around 3-4, consistent with the broad lognormal distributions that were assumed as prior distributions for these parameters. A comparison of posterior estimates with prior values is provided in Table 3 ; this gives the geometric mean ratio (and GSD) of the ratio of posterior median: prior median value for the rate from the ALV to bb region (Table 3 ) and for the rate from the ALV to INT (Table 3) . On average, the results suggest that for the clearance pathway ALV to bb, the posterior median values are higher than the prior values; but are lower than the prior value for the clearance pathway from ALV to INT. For all workers, however, the 95% posterior probability interval of each particle transport rate contained the prior median value.
• For intakes, the posterior median values were compared with the total amount of intake expected for each case calculated using the intake distribution described by Sokolova et al. (18) . This intake is therefore the same as the median value of the prior intake that was used to calculate organ doses for these workers under MWDS-2013. The geometric mean of posterior median: expected values was on average around a factor of 4; although the 95% range of ratios observed for all workers consisted of values less than unity. Note that a factor of 4 should be considered alongside the significant uncertainty (a factor of 2-10) about the median value of the intake prior inferred from air monitoring data (18) and the fact that an arbitrarily wide and uninformative intake prior was used in this analysis, which would positively skew the posterior estimates to higher values than if the lognormal prior has been used. Table 4 summarises the results of the analysis of the plutonium oxide cases. The main points of interest are:
Plutonium oxides
• The mean and median values of s s for the plutonium oxide exposures (Table 4 ) are more variable than observed for the plutonium nitrates (Table 2 ), but typically have values between 2 × 10 −5 d −1 and 10 × 10
• The oxide posterior median values of the particle transport rates differed from their prior median values to a greater extent than were observed for the plutonium nitrate exposures (see Table 3 ), although the geometric differences were in the same direction for both rates: posterior medians for ALV to bb were higher, rates from ALV to INT were lower. However, the posterior distributions of particle transport clearance parameters were broad and, in nearly all cases, the 95% posterior probability interval contained the prior median value.
• As with the plutonium nitrate exposures, the posterior median values of intake were on average around a factor of 4 higher than the expected values, indicated by the geometric mean difference between posterior median: expected value.
Goodness-of-fit
For all analyses (nitrates and oxides), it was found that the biokinetic model and sampled parameter values were broadly consistent with the data: 10-30% of parameter vectors sampled using the WeLMoS method gave Maximum Likelihood Estimates of intake with χ 2 alpha probabilities >0.05. The frequency of parameter vectors giving acceptable fits should be considered a qualitative indicator of consistency between the model and data, because it is dependent on the absolute range of parameter values chosen to represent the uniform prior on s s when the WeLMoS method is applied (this is a range considered by the analyst to give adequate coverage of values of the parameter over the range of the likelihood), and as a consequence may consist of additional regions not favoured by it-a full description of the method and its strengths and weaknesses can be found in Puncher and Birchall. (20) 
Shared Bayesian analyses of nitrate and oxide case histories
The 'shared' analyses of the plutonium nitrate and oxide exposures are provided in Tables 5 and 6 , GSD, SD and Q refer to the geometric standard deviation, the standard deviation and the 95% confidence interval. a (Brackets) excludes case 8795. b Derived from posterior medians, assuming posterior distributions of individual estimates cases are lognormal and medians are lognormally distributed (log of medians fit lognormal better than normal). Individual estimates obtained from the data of each of the 20 MPA plutonium oxide workers by worker ID. GSD, SD and Q refer to the geometric standard deviation, the standard deviation and the 95% confidence interval. a Worker spent most of the time, excluding periods spent in 'reactor' or 'aux' locations, working with plutonium oxide so that more than 80% of the inhaled activity was oxide. b Workers assumed to have been exposed only to plutonium oxide: most of the working history was spent working with plutonium oxide in location 'main' but time was also spent working in 'reactor' or 'aux' locations where no exposure to plutonium is thought to have occurred. c Workers spent their whole working history handling plutonium oxide materials and therefore were only exposed to this material. d These units are 10
value (if absorption is assumed to be an entirely physiological process) or crude estimate of the true value (if absorption is assumed to be an entirely physico-chemical process but has a rate that is fixed but unknown), together with the standard error (as a 95% confidence or probability interval). The statistics were obtained from the posterior median values of the distributions derived from the analyses of the individual cases given in Tables 2 and 4 , assuming that the sample medians were lognormally distributed with a median value equal to the geometric sample mean of the posterior medians, and GSD equal to the geometric sample standard deviation of the posterior medians. The posterior estimates of s s obtained from the analysis of individual cases and groups of five cases are consistent with the shared estimates obtained from the analysis of all 20 cases, for both nitrate and oxides. The only exception was Group 2 in the plutonium nitrate analysis, which was affected by outlier case 8795; excluding this case gave values of s s that were consistent with those determined from the other groups. The results of Calculations 1 and 2 are also consistent with the shared estimates of all 20 cases (Calculation 3, below). Taken together, these results suggest that the shared estimates are robust and the group of workers is representative of Mayak workers exposed to plutonium nitrates and oxides. It also supports the idea that dissolution is dependent on the physico-chemical form of the inhaled material. It should be noted that by treating s s as a shared parameter (within the group), the uncertainty on its estimate is dramatically reduced from that obtained by more traditional method of treating each estimate of s s separately, and combining using standard statistical methods. This bodes well for future epidemiological analysis, which aims at treating shared and unshared uncertainties explicitly.
Calculation 3 provides the best estimate of the slow dissolution rate, s s , conditioned on the assumption that dissolution is an entirely material-specific process-and thus assumes the same value for each individual. The following results are consistent with this assumption:
• The values of χ 2 alpha probabilities from the Maximum Likelihood fitting of sampled parameters in the MCMC analysis of all 20 cases support this assumption: it was found that for all 20 oxide cases and 17 of the nitrate cases, the posterior distribution of χ 2 alpha values had median values that were >0.05 (and were typically in the region of 0.4-0.5).
• The posterior values of other parameters were similar to those reported in the analyses of individual cases above, in that posterior median values of intake were on average around 3-and 6-fold higher than the level of intake expected for nitrate and oxide cases, respectively. As observed for the analyses of the individual case, posterior estimates of the particle transport parameters for each worker were broad, consistent with the broad lognormal prior distributions assumed for these parameters; in most cases the 95% posterior range of values contained the prior median value. Comparisons of posterior medians with prior medians are provided in Table 3 ; the differences in the ratios are consistent with those observed in the analyses of the individual cases (described above): the rates from the ALV to the bronchial/bb are on average higher than the prior values for both nitrate and oxide exposures. In Table 6 . Posterior probability distributions (estimates) of s s (×10 −5 ) (d −1 ) for plutonium oxide derived from groups of workers.
Groups of 5 workers (shared)
All 20 workers GSD, SD and Q refer to the geometric standard deviation, the standard deviation and the 95% confidence interval. a Derived from posterior medians, assuming posterior distributions of individual estimates cases are lognormal and medians are lognormally distributed (logged medians fit lognormal better than normal).
contrast, the rate from the ALV to interstitium is lower than the prior value. Note, however, that the GSDs in Table 3 indicate that there is a large spread in the ratio of posterior median:prior median for the 20 nitrate or 20 oxide cases.
It is difficult to depict a graph showing goodness-offit in two dimensions for the shared analyses of the 20 oxides or nitrate cases because of the multidimensional parameter space of the prior (each MCMC run consists of 60 parameters, since for unshared parameters, each worker has his own independent parameter). However, a useful visual assessment of consistency between model and data is to compare the lung and systemic retention predicted for each case assuming the derived values of the slow dissolution rate and the prior median values of the particle transport parameters, with the observed values (the data). Predicted ratios of Lung:Whole Body (WB) content, represented by the trend lines in Figure 1 , are those obtained assuming the median values of 2.58 × 10 −4 (nitrates) and 4.7 × 10
(oxides). The WB content of plutonium for each worker (actual and predicted) was obtained using the following equation:
Whole Body activity Bq lung LNTH skeleton liver /0.9 3
where lung, LNTH, skeleton and liver are the activities obtained from autopsy measurements for these workers. The combined skeleton and liver activity was scaled to obtain an estimate of total systemic burden, assuming 90% of the systemic activity is in these organs at death (17) (many years after the exposure).
The protracted nature of the pattern of intake makes the choice of a suitable definition of time between intake and measurement (death) for the plots difficult. In recognition of this, the time since exposure in the figures is represented in two ways:
• Time since median intake. The amount of time between the point in the exposure period where the cumulative intake is exactly half of the total intake, as determined using the intake function described by Birchall et al. (this issue) , and the time of death (top panel in Figure 1a and b). It is worth noting from the plots based on this criteria that the earliest time point between intake and death is around 5 years.
• Time since end of intake. The amount of time between the end of the exposure period and the time of death (bottom panel in Figure 1c and d).
Consideration of two time metrics is pertinent given that the exposure pattern is a chronic one and assumes very high intakes at early times in most cases. The plots show good agreement between the trend in predicted versus observed Lung: WB content for the 40 nitrate exposures, although there is clearly a large amount of variation about the trend. Note that the values of s s are those that best describe the entire worker data. If the prior median values of the particle transport rates also described (fitted) the rate of particle transport clearance for each individual, then the data would precisely coincide with the plotted lines; in the MCMC analyses these rates were allowed to vary in order to determine the best value (or more precisely range of values) for each individual. Consequently, the deviation of each individual data-point from the trend line results from the fact that the particle transport clearance rates for each worker are different (a result of natural inter-subject variability); hence, the graph should NOT be used to assess the goodness-of-fit of the trend line to the data. However, any bias in the trend with respect to the data suggests that the population median particle transport rates are different from the prior median values. From the plot, it appears that the 'best fitting' absorption parameters and the prior median values of the particle transport rates appear to better describe the nitrate data than they do the oxide data.
DISCUSSION
This work describes the application of Bayesian inference to estimate values of the slow dissolution rate, s s , for plutonium nitrates and oxides from autopsy data of former workers of the MPA. The results support the assumption that dissolution is entirely dependent on the physico-chemical form of the inhaled aerosol. However, this is a simplifying assumption because it is known also to depend to some extent on individual characteristics such as smoking status; smoking is thought to lead to a reduction in the rate of dissolution of moderately soluble particles (1) . The effect of smoking status on dissolution was not considered in this analysis. With regard to its effect on particle transport clearance, the ICRP Publication 130 model (unlike its ICRP Publication 66 predecessor) does not prescribe modification of the particle transport clearance rates to account for it, primarily because the data on which the revision is based did not reveal statistically significant differences in the rate of particle transport clearance from the AI region for smokers and nonsmokers (9) . In any event, any effect of smoking status on particle transport clearance is accounted for in this analysis by the use of broad prior distributions for these parameters that were derived from studies of smokers and non-smokers.
The values of s s obtained here differ markedly from those determined previously for Mayak workers by Khokhryakov et al. (7) , plutonium nitrates: 2.6 × 10 −4 d −1 (this study), 7.11 × 10 −3 d −1 (smokers) (7) ; and for plutonium oxides: 4.7 × 10 −5 d −1 (this study), 3.22 × 10 −4 d −1 (smokers) (7) . Reconciling these differences is complicated by the very different analytical and modelling approaches adopted in both studies. However, it is likely that the differences can largely be explained by the use of the ICRP Publication 66
(1) representation of particle transport clearance from the AI region by Khokhryakov et al. (7) and the revised model in this analysis. In the Khokhryakov et al. (7) study, a permanent bound fraction and a high rate of dissolution were required to explain the presence of plutonium in the lungs at late times after exposure; an assumption also made by James et al. (24) in a later analysis of USTUR case 0269 (data re-analysed in this series of publications (25) ). In contrast, this analysis demonstrates that a subset of the same data can also be explained by a suitable reduction in the rate of dissolution in conjunction with a model that predicts longer retention of insoluble particulates in the AI region.
The slow dissolution rate for plutonium oxides can be compared with values in the range of 2-7 × 10
derived from in vivo animal studies (26, 27) , although lower values in the region of 4-10 × 10 −6 d −1 have been determined from long-term human studies by Carbaugh and La Bone (28) and Gregoratto et al. (9) . The slow dissolution rate estimated here for plutonium nitrates is very much at the lower end of values obtained from in vivo studies: nitrates classified as aged 'residues' are reported as having values in the region of 2-6 × 10 −4 d −1 (26, 27) . In contrast, values for fresh materials, including those estimated from experimental human studies (29, 30) , have a rate that is around an order of magnitude higher (2 × 10 −3 d −1 ). One might suppose that a reason for this difference arises because the Mayak workers considered here were exposed to 'aged' versus 'fresh' material. However, the bulk of the exposures experienced by these workers would have occurred mainly at times prior to 1958, when plutonium production at the Mayak facility would have been highest and the level of exposure at its peak (18) ; in which case it seems more likely that workers would have experienced intakes of mainly 'fresh' nitrate at early times arising from recent reprocessing activity. If this is the case, then it is difficult to reconcile the two different estimates unless the plutonium inhaled by the Mayak workers consisted of some residual insoluble material (possibly oxalate or oxide) in addition to freshly separated nitrate, or that the solubility of the inhaled material was altered over time. On this note, one clear difference between data in the studies, such as that of Etherington et al. (29) and the present one, is the significant difference in timescale between exposure and the onset and duration of data collection. In the former study, data collection commenced shortly after intake (<1 day) and ended 120 days later; a similar pattern and duration of data collection are typically observed for animal studies involving rats, which are often used to determine lung absorption of plutonium bearing materials (31) . In contrast, for the Mayak workers the minimum time between intake and the first data-point is 5 years, with data collection continuing out to 18 years (see Figure 1) . With respect to the study of Etherington et al. (29) , 90% of the plutonium in the AI region is predicted to still be in the ALV by the time the last lung measurement was made, 120 days after the intake. However, in the case of the Mayak workers, plutonium activity remaining in the AI region is predicted to have all been transported to interstitial tissue and LNTH by the time the first autopsy data has become available, 5 years after the exposure occurred. The difference in the magnitude of the slow dissolution rate estimated from these two sets of data likely arises because the material that has migrated to the interstitium is much less soluble than material that has been freshly deposited in the fluid of the alveoli. Autoradiographs of lung tissue from humans, including Mayak workers, and dogs exposed to plutonium nitrate suggest that most of the material remaining in the interstitium is particulate (32, 33) . This material either represents an insoluble component present in the original aerosol or particulates that have been rendered insoluble during transit through interstitial tissue; for example, by becoming encapsulated in fibrous parenchymal scar tissue, or some other biological matrix that removes the particles from an aqueous environment.
In addition to dissolution, the Bayesian analysis described here also produces posterior estimates of the particle transport clearance rates from the AI region. Both the analysis of the individual cases and the shared analysis produce a posterior estimate of each rate for every worker; this estimate is only directly influenced by the data (two data-points) for the worker for whom the estimate is obtained. For this reason, the posterior estimates have a high uncertainty. However, it does appear that the median values for the rate from the ALV to the bronchial/bb are generally higher than the prior values, and vice versa for the rate from the ALV to the interstitium. This observation appears to be consistent between nitrate and oxide cases and occurs irrespective of whether the slow dissolution rate is considered to be shared or not. The particle transport clearance rates for Mayak workers is considered further in the companion paper in this series that investigates pulmonary binding of plutonium in Mayak workers (34) .
CONCLUSION
The lung and systemic burden of former Mayak workers exposed to plutonium nitrates and oxides can be explained with the revised model for alveolar clearance used to calculate doses in MWDS-2013 and the HRTM representation of dissolution. The s s value of 4.7 × 10 −5 d −1 for plutonium oxide is consistent with values estimated from other human data; however, the s s value for plutonium nitrate, 2.6 × 10
, is around an order of magnitude lower than values determined from short-term human and animal studies. The Mayak autopsy data can be explained assuming that the rate of dissolution is the same (shared) for all workers, consistent with the assumption that dissolution is essentially dependent on the physicochemical properties (solubility) of the aerosol.
